Jump Financial, LLC Myovant Sciences Ltd. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$24.03 - $27.02 $430,857 - $484,468	-17,930 Reduced 19.9%	72,159 $1.95 Million
Q3 2022 Nov 07, 2022	BUY	$11.6 - $20.44 $1.05 Million - $1.84 Million	90,089 New	90,089 $1.62 Million
Q4 2021 Feb 10, 2022	SELL	$14.31 - $23.87 $1.33 Million - $2.23 Million	-93,274 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$18.94 - $26.99 $1.77 Million - $2.52 Million	93,274 New	93,274 $2.09 Million
Q1 2021 May 17, 2021	SELL	$20.46 - $25.18 $613,411 - $754,921	-29,981 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$13.8 - $27.62 $21,817 - $43,667	1,581 Added 5.57%	29,981 $828,000
Q3 2020 Nov 13, 2020	BUY	$14.05 - $22.6 $399,020 - $641,840	28,400 New	28,400 $399,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.